Digital Marketing Campaign to Highlight Clinical-Stage Cancer Innovation OST-HER2 that activates cellular immunity against ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

In May 2024, IsoPet ® was launched as a standalone division within Vivos Inc., reaffirming the company's commitment to ...

OS Therapies, Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it has entered into ...

(RTTNews) - OS Therapies Inc. (OSTX), Tuesday announced the pricing of private placement of 1.5 million units at a price of $4.00 per unit, with each unit consisting of one share of Series A Senior ...

Paul C. Lin, M.D. Because of its technical simplicity and significant impact on improving reproductive capacity, I advocate surgical removal of the uterine septum, especially in women diagnosed ...

Ma, X. , Yuan, W. and Li, H. (2024) Primary Anaplastic Intraosseous Meningioma: Illustrative Case. Neuroscience and Medicine, ...

The adenopathy had also resolved (Figure 3D). T1a Tumor incidental histologic finding in 5% or less of tissue resected T1b Tumor incidental histologic finding in more than 5% of tissue resected ...